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ERRATUM
Volume 234, Number 2 (1997), in the minireview (Article No. VY978674) ‘‘How
Viruses Escape from Cytotoxic T Lymphocytes: Molecular Parameters and Players,’’
by Michael B. A. Oldstone, pages 179 –185: On page 180, Fig. 1 and its legend were
incorrect as printed. For the reader’s convenience, the correct Fig. 1 and its legend
are reproduced here.
This erratum is Article No. VY978876.
FIG. 1. Cartoon outlining antigen presentation by the MHC class I and
class II pathways (adapted from Whitton and Oldstone, 1996). For the class
I pathway, the thick line represents a viral protein newly synthesized in
the cell’s cytoplasm. The protein is degraded to shorter peptides in the
proteasome. A change in amino acid residues flanking the CTL epitope
(peptide) sequence can abort cleavage at this step. Peptides are translo-
cated into the ER by the TAP transport mechanism. Two peptides (l and
s) both transported to the ER are shown schematically. One of these (l)
is selected on the basis of its binding affinity by the MHC molecule, followed
by assembly of the MHC class I heavy chain peptide and MHC class I
light chain (b2M). The MHC–peptide complex passes into the Golgi and
transgolgi to reach the cell’s surface, where it is available to circulating
CD8/ CTL. For the class II pathway, the viral protein outside the cell is
taken up by endocytosis and internalized to reach an acid vesicle where
degradation to peptide fragments takes place. Meanwhile, the class II
molecule is synthesized within the ER and transported through the Golgi
network where the class II molecule-containing vesicle fuses with the endo-
some containing the fragmented protein. The class II molecule does not
bind to peptides transported into the ER because another protein, the
invariant chain (—), occupies the binding site. Later, in the endosome, the
invariant chain is degraded or lost, allowing the MHC class II molecule to
bind, again by selective affinity, to the peptide. Finally, the MHC–peptide
complex is transported to the cell’s surface where it is sought by CD4/ T
cells.
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